|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.12 CNY | +10.00% |
|
+13.15% | +35.96% |
| 08-04 | Apeloa Pharmaceutical Partners with Jitai Technology for CDMO Business | MT |
| 07-29 | Apeloa Pharmaceutical Unit Wins China Approval for Levocarnitine Oral Solution; Shares Up 5% | MT |
| Market Cap | 24.63B 3.65B 3.17B 2.95B 2.71B 5.13B 347B 5.19B 34.83B 13.62B 174B 13.7B 13.4B 575B | P/E 2026 * |
21.1x | P/E 2027 * | 20.4x |
|---|---|---|---|---|---|
| Enterprise Value | 24.16B 3.58B 3.11B 2.9B 2.66B 5.03B 340B 5.09B 34.16B 13.35B 170B 13.44B 13.15B 564B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.81x |
| Free-Float |
45.08% | Yield 2026 * |
1.45% | Yield 2027 * | 1.49% |
| 1 day | +10.00% | ||
| 1 week | +13.15% | ||
| Current month | +9.40% | ||
| 1 month | +21.27% | ||
| 3 months | +21.07% | ||
| 6 months | +16.54% | ||
| Current year | +35.96% |
| 1 week | 19.56 |  | 22.12 |
| 1 month | 17.4 | | 22.12 |
| Current year | 15.19 | | 22.12 |
| 1 year | 14.89 | | 22.12 |
| 3 years | 10.66 | | 22.12 |
| 5 years | 10.66 | | 41.87 |
| 10 years | 4.86 | | 41.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun He
CEO | Chief Executive Officer | 52 | 2024-04-08 |
Jin Hui Zhang
DFI | Director of Finance/CFO | 51 | 2019-03-06 |
Jian Guan
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Cai Xu
BRD | Director/Board Member | 60 | 2005-04-14 |
Tian Gao Hu
BRD | Director/Board Member | 61 | 2008-05-15 |
Fang Meng Zhu
CHM | Chairman | 54 | 2017-11-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.00% | +13.15% | +37.31% | +26.04% | 3.69B | |
| +4.90% | -1.87% | +55.02% | +161.49% | 995B | |
| +0.57% | -3.17% | +50.59% | +48.54% | 614B | |
| +1.72% | -6.07% | +24.56% | +64.51% | 431B | |
| +1.52% | +0.33% | +42.09% | +37.02% | 353B | |
| +0.27% | -3.56% | +31.06% | +39.25% | 293B | |
| +2.69% | -8.18% | +7.49% | +10.78% | 245B | |
| +6.10% | +6.79% | +37.95% | +63.66% | 210B | |
| -4.21% | -13.06% | -3.92% | -46.14% | 210B | |
| -2.48% | +0.20% | +18.26% | +64.87% | 168B | |
| Average | +2.07% | -3.81% | +30.04% | +47.00% | 352.19B | |
| Weighted average by Cap. | +2.04% | -5.88% | +37.63% | +73.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 1.55B 1.34B 1.25B 1.15B 2.18B 147B 2.2B 14.77B 5.77B 73.58B 5.81B 5.68B 244B | 11.34B 1.68B 1.46B 1.36B 1.25B 2.36B 160B 2.39B 16.04B 6.27B 79.91B 6.31B 6.17B 265B |
| Net income | 1.21B 180M 156M 146M 134M 253M 17.12B 256M 1.72B 672M 8.56B 676M 661M 28.36B | 1.25B 186M 161M 150M 138M 261M 17.66B 264M 1.77B 693M 8.83B 697M 682M 29.25B |
| Net Debt | -474M -70.22M -60.97M -56.85M -52.22M -98.76M -6.68B -99.85M -670M -262M -3.34B -264M -258M -11.06B | -4.05B -601M -522M -486M -447M -845M -57.13B -854M -5.73B -2.24B -28.56B -2.26B -2.21B -94.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | CN¥22.12 | +10.00% | 17,144,203 |
| 26-08-03 | CN¥20.11 | -0.54% | 14,857,680 |
| 26-07-31 | CN¥20.22 | +1.00% | 12,436,839 |
| 26-07-30 | CN¥20.02 | -3.10% | 16,062,291 |
| 26-07-29 | CN¥20.66 | +5.68% | 22,847,239 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000739 Stock
Select your edition
All financial news and data tailored to specific country editions
